[go: up one dir, main page]

DZ2944A1 - Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant. - Google Patents

Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.

Info

Publication number
DZ2944A1
DZ2944A1 DZ990244A DZ990244A DZ2944A1 DZ 2944 A1 DZ2944 A1 DZ 2944A1 DZ 990244 A DZ990244 A DZ 990244A DZ 990244 A DZ990244 A DZ 990244A DZ 2944 A1 DZ2944 A1 DZ 2944A1
Authority
DZ
Algeria
Prior art keywords
azalides
preparation
new
pharmaceutical compositions
compositions containing
Prior art date
Application number
DZ990244A
Other languages
English (en)
Inventor
Robert John Rafka
Barry James Morton
Colman Brendan Ragan
Peter Bertinato
John Philip Dirlam
Alan Elwood Blize
Cari Bernard Ziegler
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2944(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2944A1 publication Critical patent/DZ2944A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
DZ990244A 1998-11-20 1999-11-17 Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant. DZ2944A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
DZ2944A1 true DZ2944A1 (fr) 2004-03-15

Family

ID=22327457

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990244A DZ2944A1 (fr) 1998-11-20 1999-11-17 Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.

Country Status (46)

Country Link
US (1) US6329345B1 (fr)
EP (1) EP1131331B1 (fr)
JP (1) JP3842973B2 (fr)
KR (1) KR100477774B1 (fr)
CN (2) CN1326460A (fr)
AP (1) AP2001002142A0 (fr)
AR (3) AR019496A1 (fr)
AT (1) ATE260927T1 (fr)
AU (1) AU766106B2 (fr)
BG (1) BG65107B1 (fr)
BR (2) BRPI9915480B8 (fr)
CA (1) CA2351429C (fr)
CO (1) CO5380019A1 (fr)
CZ (1) CZ303099B6 (fr)
DE (1) DE69915336T2 (fr)
DK (1) DK1131331T3 (fr)
DZ (1) DZ2944A1 (fr)
EA (2) EA009729B1 (fr)
EG (1) EG23823A (fr)
ES (1) ES2216581T3 (fr)
GT (1) GT199900198A (fr)
HK (1) HK1041269A1 (fr)
HR (1) HRP20010374B1 (fr)
HU (1) HU229008B1 (fr)
ID (1) ID28548A (fr)
IL (3) IL142631A0 (fr)
IS (1) IS2350B (fr)
MA (1) MA26707A1 (fr)
ME (1) ME00467B (fr)
MY (1) MY122353A (fr)
NO (3) NO319796B1 (fr)
NZ (1) NZ511199A (fr)
OA (1) OA11713A (fr)
PA (1) PA8485601A1 (fr)
PE (1) PE20001378A1 (fr)
PL (1) PL198580B1 (fr)
PT (1) PT1131331E (fr)
RS (1) RS50302B (fr)
SI (1) SI1131331T1 (fr)
SK (1) SK284607B6 (fr)
TN (1) TNSN99214A1 (fr)
TW (2) TWI243825B (fr)
UA (1) UA70972C2 (fr)
UY (1) UY25805A1 (fr)
WO (1) WO2000031097A1 (fr)
ZA (1) ZA200104019B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
KR20020016799A (ko) * 1999-05-24 2002-03-06 데이비드 존 우드 13-메틸-에리트로마이신 유도체
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
OA12257A (en) * 2000-04-27 2003-11-06 Pfizer Prod Inc the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
WO2003014136A1 (fr) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. Composes de 11a-azalide et methode de production de ces composes
CA2529817C (fr) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Nouveaux agents antibacteriens
WO2004108744A2 (fr) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides et azaketolides possedant une activite antimicrobienne
RU2322241C2 (ru) * 2003-11-21 2008-04-20 Пфайзер Продактс Инк. Применение антибиотиков в качестве адъювантов вакцин
EP1985620A4 (fr) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd COMPOSÉ 10a-AZALIDE
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
EP2619214B1 (fr) * 2010-09-20 2014-12-24 Novartis AG Nouveau procede de fabrication de 9-deoxo-9a-aza-9a-homoerythromycin a modifie en c-4'' du cycle cladinose par un groupe epoxide
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
EP2736915A1 (fr) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Nouvelles formes cristallines de tulathromycine
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
EP3027634B1 (fr) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Procédé de préparation de tulathromycine
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
SG11202105227QA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C10-alkylene substituted 13-membered macrolides and uses thereof
AU2019385383B2 (en) * 2018-11-19 2023-06-15 President And Fellows Of Harvard College C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
ATE260927T1 (de) 2004-03-15
OA11713A (en) 2005-01-25
IS2350B (is) 2008-04-15
PL198580B1 (pl) 2008-06-30
IL189430A0 (en) 2008-06-05
CA2351429C (fr) 2005-07-12
ME00467B (me) 2011-10-10
AR019496A1 (es) 2002-02-20
YU33401A (sh) 2004-05-12
HK1041269A1 (zh) 2002-07-05
EG23823A (en) 2007-09-19
HUP0104313A3 (en) 2003-12-29
CZ20011754A3 (cs) 2002-03-13
CZ303099B6 (cs) 2012-04-04
DE69915336T2 (de) 2005-01-13
EA009729B1 (ru) 2008-02-28
PE20001378A1 (es) 2000-12-14
NO319796B1 (no) 2005-09-19
SK6632001A3 (en) 2002-07-02
BRPI9915480B1 (pt) 2015-12-29
CN1326460A (zh) 2001-12-12
AU766106B2 (en) 2003-10-09
HRP20010374A2 (en) 2002-06-30
TWI243825B (en) 2005-11-21
EA005156B1 (ru) 2004-12-30
ID28548A (id) 2001-05-31
IS5918A (is) 2001-04-17
PA8485601A1 (es) 2000-09-29
CO5380019A1 (es) 2004-03-31
RS50302B (sr) 2009-09-08
NO20012464D0 (no) 2001-05-18
WO2000031097A1 (fr) 2000-06-02
MY122353A (en) 2006-04-29
UA70972C2 (uk) 2004-11-15
NO330249B1 (no) 2011-03-14
NO329629B1 (no) 2010-11-22
JP3842973B2 (ja) 2006-11-08
NO20050893L (no) 2001-07-17
BG65107B1 (bg) 2007-02-28
GT199900198A (es) 2001-05-11
ZA200104019B (en) 2002-06-17
EA200400701A1 (ru) 2004-12-30
KR20010086043A (ko) 2001-09-07
EA200100416A1 (ru) 2001-10-22
AR059524A2 (es) 2008-04-09
DE69915336D1 (de) 2004-04-08
NO20012464L (no) 2001-07-17
HRP20010374B1 (en) 2006-09-30
BRPI9915480B8 (pt) 2022-05-10
IL142631A (en) 2010-05-31
IL189430A (en) 2010-05-31
AP2001002142A0 (en) 2001-05-09
JP2002530422A (ja) 2002-09-17
IL142631A0 (en) 2002-03-10
NO20050904L (no) 2001-07-17
EP1131331B1 (fr) 2004-03-03
MA26707A1 (fr) 2004-12-20
TW200404077A (en) 2004-03-16
BR9915480A (pt) 2001-07-31
NZ511199A (en) 2003-08-29
TNSN99214A1 (fr) 2005-11-10
PT1131331E (pt) 2004-06-30
DK1131331T3 (da) 2004-06-14
ES2216581T3 (es) 2004-10-16
HU229008B1 (en) 2013-07-29
TWI243824B (en) 2005-11-21
AR059523A2 (es) 2008-04-09
SK284607B6 (sk) 2005-07-01
SI1131331T1 (en) 2004-08-31
CN101367853A (zh) 2009-02-18
EP1131331A1 (fr) 2001-09-12
BG105600A (en) 2001-12-29
AU1068600A (en) 2000-06-13
US6329345B1 (en) 2001-12-11
HUP0104313A2 (hu) 2002-02-28
KR100477774B1 (ko) 2005-03-21
CA2351429A1 (fr) 2000-06-02
PL347784A1 (en) 2002-04-22
UY25805A1 (es) 2001-08-27

Similar Documents

Publication Publication Date Title
DZ2944A1 (fr) Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
MA26659A1 (fr) Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2891A1 (fr) Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3000A1 (fr) Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
DZ2963A1 (fr) Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr) Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3020A1 (fr) Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr) Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2889A1 (fr) 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr) Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2773A1 (fr) Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3045A1 (fr) Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2745A1 (fr) BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26551A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2866A1 (fr) 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2777A1 (fr) Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26490A1 (fr) Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.